Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000315066-25-001449·Ascendis Pharma A/S
Schedule 13G ownership disclosure
ASCENDIS PHARMA A/S
COMMON STOCK · CUSIP: 04351P101
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 4,646,943.00 · Class: 8.0%
- Abigail P. Johnson
Shares: 4,646,943.00 · Class: 8.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-001449
- Form type
- SCHEDULE 13G/A
- Filer
- Ascendis Pharma A/S
- CIK
- CIK 1612042
- Filed
- May 12, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership